HealthTech Israel Podcast

Daniella Gilboa, CEO AIVF

October 26, 2021 Chen Sirkis Season 2 Episode 4
Daniella Gilboa, CEO AIVF
HealthTech Israel Podcast
More Info
HealthTech Israel Podcast
Daniella Gilboa, CEO AIVF
Oct 26, 2021 Season 2 Episode 4
Chen Sirkis

Today we're speaking to Daniella Gilboa, CEO of AIVF. A company that is out to transform the fertility and IVF treatment journey. Daniella was an embryologist for more than 15 years before establishing AIVF. And she's a biostatistician too. 

00:55 We'd like to hear about your personal journey. What is the process that leads an embryologist to establish an AI driven IVF company?

07:42 You have said that you believe that being an embryologist is probably one of the most noble professions in the world. What did you mean by that?

09:12 What made you feel like you have the tools to take this endeavor forward as its CEO?  

11:47 What in your eyes are the problems in the current status of IVF and the journey in which women are trying to or families are trying to conceive?

19:15 What would be the role of the embryologist going forward, once you have this technology out in the market? 

22:45 How do you bring patients into the equation of IVF transformation? 

31:51 How does the AIVF solution work? 

35:02 Can you tell us where you are in the AIVF journey in terms of the product and regulation and market?

38:16 How is Dan Ariely involved with the company and what does her behavioral economics have to do with IVF?

43:36  Is there an element of the product right now that connects to the patients? Will the patient be able to follow what is happening with their embryo, remotely, while everything's happening.

47:46 Why aren't there more female CEOs in healthtech?

50:55 What is your best tip for a scientist who is thinking about opening a startup?

 

Show Notes

Today we're speaking to Daniella Gilboa, CEO of AIVF. A company that is out to transform the fertility and IVF treatment journey. Daniella was an embryologist for more than 15 years before establishing AIVF. And she's a biostatistician too. 

00:55 We'd like to hear about your personal journey. What is the process that leads an embryologist to establish an AI driven IVF company?

07:42 You have said that you believe that being an embryologist is probably one of the most noble professions in the world. What did you mean by that?

09:12 What made you feel like you have the tools to take this endeavor forward as its CEO?  

11:47 What in your eyes are the problems in the current status of IVF and the journey in which women are trying to or families are trying to conceive?

19:15 What would be the role of the embryologist going forward, once you have this technology out in the market? 

22:45 How do you bring patients into the equation of IVF transformation? 

31:51 How does the AIVF solution work? 

35:02 Can you tell us where you are in the AIVF journey in terms of the product and regulation and market?

38:16 How is Dan Ariely involved with the company and what does her behavioral economics have to do with IVF?

43:36  Is there an element of the product right now that connects to the patients? Will the patient be able to follow what is happening with their embryo, remotely, while everything's happening.

47:46 Why aren't there more female CEOs in healthtech?

50:55 What is your best tip for a scientist who is thinking about opening a startup?